
Image: Ibrahim Boran
Scientists have taken another big step forward towards developing a vaccine that’s effective against the most severe forms of malaria.
Professor Denise Doolan from James Cook University’s Australian Institute of Tropical Health and Medicine (AITHM) was part of an international team that narrowed down the malaria proteins and disease-fighting antibodies that could be used to develop a vaccine against severe malaria.
She said according to the latest figures from the World Health Organisation, there were 219 million cases of malaria worldwide in 2017, leading to an estimated 435,000 deaths.
“What makes this work so difficult is the particular survival strategy of the malaria parasite in the human body. It grows within blood cells and inserts proteins into the surface of the blood cell so it sticks to the walls of blood vessels,” Professor Doolan said.
“But it changes these proteins to escape from immune responses, and every strain has a different set of proteins, making the identification of vaccine targets extraordinarily hard.”
The team of collaborators – involving JCU, the Walter and Eliza Hall Institute of Medical Research (WEHI) at Deakin University, and malaria experts from Papua New Guinea, France and the USA – collected hundreds of PfEMP1 proteins from malaria strains from children in PNG who had been naturally infected by the disease, made a custom protein microarray of those strains, and then examined serum samples to identify which of the many PfEMP1 variants were associated with protection.
The research team managed to pinpoint which antibodies were most effective in fighting the most severe forms of malaria.
Associate Professor Alyssa Barry, who leads the Systems Epidemiology of Infection unit within the Deakin School of Medicine, said the findings from the project were a major step towards developing a viable vaccine for the disease.
“It’s the first time anyone has shown this – for years, researchers have thought that developing a malaria vaccine based on PfEMP1 would be virtually impossible, because the proteins are just so diverse,” Associate Professor Barry said.
“It’s similar to the flu vaccine, where you have to keep adjusting and updating it as the virus strains evolve from year to year. Malaria is even more diverse than influenza – one village in a country such as PNG could contain thousands of possible malaria strains. But in malaria-endemic areas, children who are repeatedly infected develop immunity to severe malaria by the time they’re about two years old, so we know antimalarial immunity is possible, and it can develop after exposure to only a few strains.”
Associate Professor Barry said while immunity to milder forms of malaria presented a “formidable obstacle”, immunity to severe malaria targets only a small subset of proteins that have many similarities between strains – making the essential components for a vaccine much easier to identify.
“Using genomic sequencing, we collected PfEMP1 proteins from different strains of malaria, measured antibodies to those proteins and then used machine learning to identify the protective antibody – the biomarker of immunity – that protects kids against disease,” she said.
“We were able to identify these antibodies by monitoring for patterns of disease, following the children in PNG for 16 months to determine which of them were susceptible to the more severe forms of the disease, and those who were protected and only experienced milder forms of the disease.
“It’s been a long road, and has involved a large team, but it’s a major step forward, and this provides hope that creating a vaccine might be possible.”
The full research findings, “Protective immunity against severe malaria in children is associated with a limited repertoire of antibodies to conserved PfEMP1 variants”, were published today in the scientific journal Cell Host & Microbe.
Learn more: Scientists close in on malaria vaccine
The Latest on: Malaria
- 15.70L persons take malaria test in Chhattisgarhon January 21, 2021 at 10:53 am
Under the ‘Malaria Mukt Chhattisgarh Abhiyan’ launched by the State Health Department, 15.70 lakh people have been tested in Surguja and Bastar districts. The first phase of the programme was launched ...
- South African Scientists Make ‘Breakthrough’ in Killing Malaria Before It’s Infectiouson January 21, 2021 at 3:25 am
South African scientists have identified a new chemical compound that has the ability to treat malaria and even kill the malaria parasite before it becomes infectious. The discovery was made by ...
- Newly discovered chemical could be a solution to malariaon January 20, 2021 at 9:03 am
A new chemical has been discovered by a research team which could potentially eliminate malaria. The chemical compound was discovered by researchers at the University of Pretoria (UP). South Africa is ...
- Malaria Diagnostics Market Size 2021 to 2026, Forthcoming Developments, Business Opportunities, Market Upside and Future Investmentson January 19, 2021 at 2:35 am
Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Malaria Diagnostics Market” ...
- Malaria Vaccines Market Size 2020 Analysis and In-depth Research on Trends, Emerging Growth Factors and Forecast to 2024on January 19, 2021 at 2:28 am
Malaria Vaccines Market” forecast 2020-2024 report analyses the current and future competitive scenario of the global Healthcare , Pharmaceuticals industry. Malaria Vaccines ...
- How fighting malaria is helping to tackle Covid-19 around the worldon January 18, 2021 at 8:26 pm
ADVERTISER CONTENT FROM COMIC RELIEF AND GSK HOSTED BY THE GUARDIAN | Covid-19 could undo the progress made against malaria – one of the world’s deadliest diseases ...
- 'They use SMS, voicemail and chat apps': how young reporters in Sierra Leone are documenting the impact of malariaon January 18, 2021 at 8:21 pm
ADVERTISER CONTENT FROM COMIC RELIEF AND GSK HOSTED BY THE GUARDIAN | A network of reporters is investigating the impact of malaria and Covid-19 on communities ...
- South African scientists discover new chemicals that kill malaria parasiteon January 15, 2021 at 1:02 pm
South African scientists have discovered chemical compounds that could potentially be used for a new line of drugs to treat malaria and even kill the parasite in its infectious stage, which most ...
- Scientists artificially infect mosquitoes with human malaria to advance treatmenton January 14, 2021 at 8:44 am
A vector refers to an organism that carries and transmits an infectious disease, as mosquitoes do malaria. Lead compounds are chemical compounds that show promise as treatment for a disease and may ...
- Wits University scientists artificially infect mosquitoes with human malaria to advance treatmenton January 14, 2021 at 8:10 am
Scientists at the Wits Research Institute for Malaria (WRIM) in partnership with the University of Pretoria and colleagues in the US, Spain and Switzerland have identified novel antiplasmodial lead ...
via Bing News
The Latest on: Malaria vaccine
- Governors Distance Themselves From Yahaya Bello’s Comments On COVID-19 Vaccineon January 21, 2021 at 9:39 am
The Nigeria Governor’s Forum on Thursday distanced itself from comments made by Kogi State Governor Yahaya Bello on the COVID-19 vaccine. Speaking to a crowd recently Bello had condemned the use of ...
- COVID-19 vaccine as agent of death: Governors disown Belloon January 21, 2021 at 8:05 am
Bello of Kogi State over claim that the COVID vaccine is an agent of death meant to kill people. The governors under the auspices of Nigeria Governors Forum (NGF), have therefore, stressed that they ...
- Yvonne Chaka Chaka splits social media with Covid-19 vaccine commentson January 21, 2021 at 12:45 am
Veteran musician and humanitarian Yvonne Chaka Chaka sparked fierce debate on social media after questioning the production of the Covid-19 vaccine. The Umqombothi hitmaker took to social media this ...
- Local trial of COVID-19 vaccine critical — Prof. Dodooon January 21, 2021 at 12:18 am
A clinical pharmacologist, Professor Alex Dodoo, has suggested that the country should conduct local clinical trials for COVID-19 vaccines to help settle on a suitable one for the people.
- Covid-19 vaccine team finalises Kenya rollout planon January 19, 2021 at 4:00 pm
Kenya is currently putting final touches to its Covid-19 vaccine roadmap.The 11-member vaccine advisory team says that it will officially submit its recommendations to President Uhuru ...
- Malaria Vaccines Market Size 2020 Analysis and In-depth Research on Trends, Emerging Growth Factors and Forecast to 2024on January 19, 2021 at 2:28 am
Malaria Vaccines Market” forecast 2020-2024 report analyses the current and future competitive scenario of the global Healthcare , Pharmaceuticals industry. Malaria Vaccines ...
- This company threatened to ax workers refusing the vaccine, by threatening a ‘no jab, no job policy’on January 15, 2021 at 12:21 pm
One of Britain’s best-known plumbing firms also refused to employ people in the future unless they have the COVID-19 vaccine.
- In-Depth Analysis of Vaccines Market by Top Key Players, Industry Insights, Global Opportunities, Regional Overview, Growth Trends, Forecast to 2026on January 12, 2021 at 1:35 am
The global “Vaccines Market Size” is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing ...
- A New Target for Malaria Vaccineson January 8, 2021 at 4:43 am
An article published in Experimental Biology and Medicine (Volume 246, Issue 1, January, 2021, [] ) describes a new target for the development therapies and vaccines for malaria. The study from the We ...
via Bing News